Return of BioPharm America™ 2013 to Boston Will Draw Leading International Life Science Dealmakers to Northeast

Return of BioPharm America™ 2013 to Boston Will Draw Leading International Life Science Dealmakers to Northeast

EBD GroupErin Righetti, +1-760-930-0500orMassBioSarah MacDonald, +1-617-674-5115

EBD Group, the leading partnering firm for the life science industry, in collaboration with the Massachusetts Biotechnology Council (MassBio) announced today that 2013 will again be held in Boston September 17–19 at the in Boston, MA.

Senior executives from big pharma are set to attend, including AstraZeneca, Bayer HealthCare, EMD Serono, Janssen, Merck, Novo Nordisk, Shire, and more. Program topics cover trends in healthcare and drug development and other timely issues for industry insiders. Spotlight panels and roundtables will also feature industry leaders in discussions on innovative partnerships, emerging markets and global drug development strategies. The 2012 edition welcomed over 750 delegates representing 462 companies from 30 countries. Delegates in 2012 engaged in 1,846 one-to-one partnering meetings with 652 licensing opportunities.

“Boston is a biotechnology innovation hub. There are more than 500 companies focused on pharmaceutical and biotech drug discovery located in Massachusetts, from small start-ups to large established pharmaceuticals,” said , President of EBD Group. “This creates an ideal environment for partnering, and is what draws the global biotech sector to BioPharm America.”

“At MassBio, our focus is to promote world class biotechnology in Massachusetts, and BioPharm America is the forum that enables regional biotech companies to identify and enter into strategic relationships at the global level,” said President and CEO of MassBio. “The partnering at BioPharm America, and particularly the process of meeting face-to-face to discuss novel assets, is a definite advantage in the culmination of any deal.”

BioPharm America 2013 will again celebrate the announcement of the Fierce 15, selected for their pioneering technology and innovative business models, with, Editor-in-Chief of FierceBiotech, featured on a panel with several Fierce 15 CEOs to discuss the industry outlook for the life sciences.

One-to-one networking at BioPharm America™ is powered by , the leading conference networking solution for the life sciences.

Register before July 19, 2013 to save USD 200 at . MassBio members receive an additional USD 200 discount by adding the code ‘MassBio’ in the comments field of the online registration form.

Presenting companies should submit an application by June 28, 2013 at .

BioPharm America is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®.

Additional links and information:

Follow BioPharm America 2013 on Twitter: (hashtag: #BPA13)

Entry to BioPharm America 2013 is free to members of the press, including full access to the partnering system, sessions, press conferences, workshops, and pre-arranged partnering meetings. Visit the BioPharm America conference website at for press registration details. In addition, Business Wire, the official News Release Distribution and Online Press Kit service for BioPharm America™ 2013, is offering to enhance your public relations efforts.

MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing the development of critical new science, technology and medicines that benefit people worldwide. Representing over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, MassBio works to advance policy and promote education, while providing member programs and events, industry information, and services.

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

EBD Group’s sophisticated web-based partnering service, , is also used as the partnering engine at numerous third-party events around the world, and is the open online community of life science dealmakers that enhances partnering experiences all year long. Outside of the conference format, EBD Group’s consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.

EBD Group has offices in the USA and Europe.

For more information please visit .

Suggested Articles

When it’s time to go public, most biotech companies for the Nasdaq. Not so for SQZ Biotech, which raised $71 million in its NYSE debut.

The saga of COVID antibody R&D continues as the REGN-COV2 antibody cocktail used by President Donald Trump has been hit by safety concerns.

A Dartmouth-led team proposed a method for targeting and inhibiting the most aggressive cells in breast tumors to improve responses to chemotherapy.